{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:51:55Z","timestamp":1789390315944,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T00:00:00Z","timestamp":1274313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T00:00:00Z","timestamp":1274313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1038\/leu.2010.97","type":"journal-article","created":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T05:43:59Z","timestamp":1274334239000},"page":"1325-1334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation"],"prefix":"10.1038","volume":"24","author":[{"given":"K","family":"Mizrahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pearl-Yafe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Yaniv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Askenasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,20]]},"reference":[{"key":"BFleu201097_CR1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","volume":"3","author":"BB Aggarwal","year":"2003","unstructured":"Aggarwal BB . Signaling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003; 3: 745\u2013756.","journal-title":"Nat Rev Immunol"},{"key":"BFleu201097_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/jcp.20099","volume":"201","author":"R Di Pietro","year":"2004","unstructured":"Di Pietro R, Zauli G . Emerging non-apoptotic functions of tumor necrosis factor related apoptosis-inducing ligand (TRAIL)\/Apo2L. J Cell Physiol 2004; 201: 331\u2013340.","journal-title":"J Cell Physiol"},{"key":"BFleu201097_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cytogfr.2006.04.002","volume":"17","author":"G Zauli","year":"2006","unstructured":"Zauli G, Secchiero P . The role of the TRAIL\/TRAIL receptors system in hematopoiesis and endothelial cell biology. Cytokine Growth Factor Rev 2006; 17: 245\u2013257.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFleu201097_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/MOH.0b013e3282f15fa6","volume":"15","author":"P Secchiero","year":"2008","unstructured":"Secchiero P, Zauli G . Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis. Curr Opin Hematol 2008; 15: 42\u201348.","journal-title":"Curr Opin Hematol"},{"key":"BFleu201097_CR5","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1158\/1078-0432.CCR-06-2774","volume":"13","author":"C Carlo-Stella","year":"2007","unstructured":"Carlo-Stella C, Lavazza C, Locatelli A, Vigan\u00f2 L, Gianni AM, Gianni L . Targeting TRAIL agonistic receptors for cancer therapy. Clin Cancer Res 2007; 13: 2313\u20132317.","journal-title":"Clin Cancer Res"},{"key":"BFleu201097_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/10428190701713655","volume":"49","author":"ES Henson","year":"2008","unstructured":"Henson ES, Johnston JB, Gibson SB . The role of TRAIL death receptors in the treatment of hematological malignancies. Leuk Lymphoma 2008; 49: 27\u201335.","journal-title":"Leuk Lymphoma"},{"key":"BFleu201097_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ctrv.2008.11.006","volume":"35","author":"D Mahalingam","year":"2009","unstructured":"Mahalingam D, Szegezdi E, Keane M, Jong S, Samali A . TRAIL receptor signalling and modulation: Are we on the right TRAIL? Cancer Treat Rev 2009; 35: 280\u2013288.","journal-title":"Cancer Treat Rev"},{"key":"BFleu201097_CR8","doi-asserted-by":"publisher","first-page":"6304","DOI":"10.1158\/0008-5472.CAN-05-3501","volume":"66","author":"K Song","year":"2006","unstructured":"Song K, Benhaga N, Anderson RL, Khosravi-Far R . Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo. Cancer Res 2006; 66: 6304\u20136311.","journal-title":"Cancer Res"},{"key":"BFleu201097_CR9","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1089\/hum.2006.17.1225","volume":"17","author":"C Carlo-Stella","year":"2006","unstructured":"Carlo-Stella C, Lavazza C, Di Nicola M, Cleris L, Longoni P, Milanesi M et al. Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand. Hum Gene Ther 2006; 17: 1225\u20131240.","journal-title":"Hum Gene Ther"},{"key":"BFleu201097_CR10","doi-asserted-by":"publisher","first-page":"9614","DOI":"10.1158\/0008-5472.CAN-08-0451","volume":"68","author":"SM Kim","year":"2008","unstructured":"Kim SM, Lim JY, Park SI, Jeong CH, Oh JH, Jeong M et al. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res 2008; 68: 9614\u20139623.","journal-title":"Cancer Res"},{"key":"BFleu201097_CR11","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.1073\/pnas.0806647106","volume":"106","author":"LS Sasportas","year":"2009","unstructured":"Sasportas LS, Kasmieh R, Wakimoto H, Hingtgen S, van de Water JA, Mohapatra G et al. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci USA 2009; 106: 4822\u20134827.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201097_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1359-6101(03)00021-2","volume":"14","author":"PW Dempsey","year":"2003","unstructured":"Dempsey PW, Doyle SE, He JQ, Cheng G . The signalling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 2003; 14: 193\u2013209.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFleu201097_CR13","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0006-2952(03)00490-8","volume":"66","author":"U Gaur","year":"2003","unstructured":"Gaur U, Aggarwal BB . Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003; 66: 1403\u20131408.","journal-title":"Biochem Pharmacol"},{"key":"BFleu201097_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1359-6101(03)00032-7","volume":"14","author":"CF Ware","year":"2003","unstructured":"Ware CF . The TNF superfamily. Cytokine Growth Factor Rev 2003; 14: 181\u2013184.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFleu201097_CR15","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.biocel.2007.02.007","volume":"39","author":"C Falschlehner","year":"2007","unstructured":"Falschlehner C, Emmerich CH, Gerlach B, Walczak H . TRAIL signalling: decisions between life and death. Int J Biochem Cell Biol 2007; 39: 1462\u20131475.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFleu201097_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/ni.1714","volume":"10","author":"NS Wilson","year":"2009","unstructured":"Wilson NS, Dixit V, Ashkenazi A . Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat Immunol 2009; 10: 348\u2013355.","journal-title":"Nat Immunol"},{"key":"BFleu201097_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/46809","volume":"401","author":"R De Maria","year":"1999","unstructured":"De Maria R, Zeuner A, Eramo A, Domenichelli C, Bonci D, Grignani F et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 1999; 401: 489\u2013493.","journal-title":"Nature"},{"key":"BFleu201097_CR18","first-page":"3716","volume":"95","author":"L Zamai","year":"2000","unstructured":"Zamai L, Secchiero P, Pierpaoli S, Bassini A, Papa S, Alnemri ES et al. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood 2000; 95: 3716\u20133724.","journal-title":"Blood"},{"key":"BFleu201097_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1182\/blood-2003-06-2137","volume":"103","author":"P Secchiero","year":"2004","unstructured":"Secchiero P, Melloni E, Heikinheimo M, Mannisto S, Di Pietro R, Zauli G . TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. Blood 2004; 103: 517\u2013522.","journal-title":"Blood"},{"key":"BFleu201097_CR20","first-page":"2770","volume":"59","author":"GS Wu","year":"1999","unstructured":"Wu GS, Burns TF, Zhan Y, Alnemri ES, El-Deiry WS . Molecular cloning and functional analysis of the mouse homologue of the KILLER\/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Cancer Res 1999; 59: 2770\u20132775.","journal-title":"Cancer Res"},{"key":"BFleu201097_CR21","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1074\/jbc.M210783200","volume":"278","author":"P Schneider","year":"2003","unstructured":"Schneider P, Olson D, Tardivel A, Browning B, Lugovskoy A, Gong D et al. Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Biol Chem 2003; 278: 5444\u20135454.","journal-title":"J Biol Chem"},{"key":"BFleu201097_CR22","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1038\/sj.leu.2401501","volume":"13","author":"Y Gazitt","year":"1999","unstructured":"Gazitt Y . TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells. Leukemia 1999; 13: 1817\u20131824.","journal-title":"Leukemia"},{"key":"BFleu201097_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/sj.leu.2402338","volume":"16","author":"M Plasilova","year":"2002","unstructured":"Plasilova M, Zivny J, Jelinek J, Neuwirtova R, Cermak J, Necas E et al. TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors. Leukemia 2002; 16: 67\u201373.","journal-title":"Leukemia"},{"key":"BFleu201097_CR24","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/sj.leu.2402960","volume":"17","author":"NS Lee","year":"2003","unstructured":"Lee NS, Cheong HJ, Kim SJ, Kim SE, Kim CK, Lee KT et al. Ex vivo purging of leukemia cells using tumor-necrosis-factor-related apoptosis-inducing ligand in hematopoietic stem cell transplantation. Leukemia 2003; 17: 1375\u20131383.","journal-title":"Leukemia"},{"key":"BFleu201097_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/5517","volume":"5","author":"H Walczak","year":"1999","unstructured":"Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999; 5: 157\u2013163.","journal-title":"Nat Med"},{"key":"BFleu201097_CR26","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1073\/pnas.030545097","volume":"97","author":"AM Chinnaiyan","year":"2000","unstructured":"Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci USA 2000; 97: 1754\u20131759.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201097_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1172\/JCI6926","volume":"104","author":"A Ashkenazi","year":"1999","unstructured":"Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999; 104: 155\u2013162.","journal-title":"J Clin Invest"},{"key":"BFleu201097_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0002-9440(10)62277-8","volume":"166","author":"D Campioni","year":"2005","unstructured":"Campioni D, Secchiero P, Corallini F, Melloni E, Capitani S, Lanza F et al. Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes. Am J Pathol 2005; 166: 557\u2013563.","journal-title":"Am J Pathol"},{"key":"BFleu201097_CR29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.leukres.2005.09.015","volume":"30","author":"T Kakagianni","year":"2006","unstructured":"Kakagianni T, Giannakoulas NC, Thanopoulou E, Galani A, Michalopoulou S, Kouraklis-Symeonidis A et al. A probable role for TRAIL-induced apoptosis in the pathogenesis of marrow failure. Implications from an in vitro model and from marrow of aplastic anemia patients. Leuk Res 2006; 30: 713\u2013721.","journal-title":"Leuk Res"},{"key":"BFleu201097_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1615\/CritRevImmunol.v23.i4.30","volume":"23","author":"R Greil","year":"2003","unstructured":"Greil R, Anether G, Johrer K, Tinhofer I . Tuning the rheostat of the myelopoietic system via Fas and TRAIL. Crit Rev Immunol 2003; 23: 301\u2013322.","journal-title":"Crit Rev Immunol"},{"key":"BFleu201097_CR31","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/sj.leu.2403383","volume":"18","author":"U Testa","year":"2004","unstructured":"Testa U . Apoptotic mechanisms in the control of erythropoiesis. Leukemia 2004; 18: 1176\u20131199.","journal-title":"Leukemia"},{"key":"BFleu201097_CR32","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1634\/stemcells.2007-0402","volume":"25","author":"M Pearl-Yafe","year":"2007","unstructured":"Pearl-Yafe M, Stein J, Yolcu ES, Farkas DL, Shirwan H, Yaniv I et al. Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors. Stem Cells 2007; 25: 3194\u20133203.","journal-title":"Stem Cells"},{"key":"BFleu201097_CR33","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.exphem.2007.07.010","volume":"35","author":"M Pearl-Yafe","year":"2007","unstructured":"Pearl-Yafe M, Yolcu ES, Stein J, Kaplan O, Shirwan H, Yaniv I et al. Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis. Exp Hematol 2007; 35: 1601\u20131612.","journal-title":"Exp Hematol"},{"key":"BFleu201097_CR34","first-page":"545","volume":"14","author":"DT Harris","year":"1994","unstructured":"Harris DT, LoCascio J, Besencon FJ . Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease. Bone Marrow Transplant 1994; 14: 545\u2013553.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu201097_CR35","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1084\/jem.191.7.1095","volume":"191","author":"K Song","year":"2000","unstructured":"Song K, Chen Y, G\u00f6ke R, Wilmen A, Seidel C, G\u00f6ke A et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 2000; 191: 1095\u20131104.","journal-title":"J Exp Med"},{"key":"BFleu201097_CR36","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/nm1202-797","volume":"8","author":"C Schmaltz","year":"2002","unstructured":"Schmaltz C, Alpdogan O, Kappel BJ, Muriglan SJ, Rotolo JA, Ongchin J et al. T cells require TRAIL for optimal graft-versus-tumor activity. Nat Med 2002; 8: 1433\u20131437.","journal-title":"Nat Med"},{"key":"BFleu201097_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1749-6632.2001.tb03575.x","volume":"938","author":"C Eaves","year":"2001","unstructured":"Eaves C, Glimm H, Eisterer W, Audet J, Maguer-Satta V, Piret J . Characterization of human hematopoietic cells with short-lived in vivo repopulating activity. Ann NY Acad Sci 2001; 938: 63\u201370.","journal-title":"Ann NY Acad Sci"},{"key":"BFleu201097_CR38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.immuni.2007.05.001","volume":"26","author":"MG Manz","year":"2007","unstructured":"Manz MG . Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity 2007; 26: 537\u2013541.","journal-title":"Immunity"},{"key":"BFleu201097_CR39","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1182\/blood-2002-01-0047","volume":"100","author":"P Secchiero","year":"2002","unstructured":"Secchiero P, Gonelli A, Mirandola P, Melloni E, Zamai L, Celeghini C et al. Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway. Blood 2002; 100: 2421\u20132429.","journal-title":"Blood"},{"key":"BFleu201097_CR40","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1084\/jem.189.8.1343","volume":"189","author":"TS Griffith","year":"1999","unstructured":"Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA . Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med 1999; 189: 1343\u20131354.","journal-title":"J Exp Med"},{"key":"BFleu201097_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/jcp.21165","volume":"214","author":"G Zauli","year":"2008","unstructured":"Zauli G, Rimondi E, Stea S, Baruffaldi F, Stebel M, Zerbinati C et al. TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors. J Cell Physiol 2008; 214: 117\u2013125.","journal-title":"J Cell Physiol"},{"key":"BFleu201097_CR42","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1634\/stemcells.2008-0512","volume":"26","author":"P Secchiero","year":"2008","unstructured":"Secchiero P, Melloni E, Corallini F, Beltrami AP, Alviano F, Milani D et al. Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells. Stem Cells 2008; 26: 2955\u20132963.","journal-title":"Stem Cells"},{"key":"BFleu201097_CR43","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.clim.2008.02.008","volume":"127","author":"JA Brown","year":"2008","unstructured":"Brown JA, Boussiotis VA . Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol 2008; 127: 286\u2013297.","journal-title":"Clin Immunol"},{"key":"BFleu201097_CR44","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1182\/blood-2006-03-011973","volume":"108","author":"S Baumann","year":"2006","unstructured":"Baumann S, Zhu JY, Giaisi M, Treiber MK, Mahlknecht U, Krammer PH et al. Wogonin sensitizes resistant malignant cells to TNF{alpha}- and TRAIL-induced apoptosis. Blood 2006; 108: 3700\u20133706.","journal-title":"Blood"},{"key":"BFleu201097_CR45","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1634\/stemcells.2007-0013","volume":"25","author":"M Pearl-Yafe","year":"2007","unstructured":"Pearl-Yafe M, Yolcu ES, Stein J, Kaplan O, Yaniv I, Shirwan H et al. Fas ligand enhances hematopoietic cell engraftment through abrogation of alloimmune responses and nonimmunogenic interactions. Stem Cells 2007; 25: 1448\u20131455.","journal-title":"Stem Cells"},{"key":"BFleu201097_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/01.moh.0000148762.05110.56","volume":"12","author":"L Burroughs","year":"2005","unstructured":"Burroughs L, Storb R . Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host disease. Curr Opin Hematol 2005; 12: 45\u201354.","journal-title":"Curr Opin Hematol"},{"key":"BFleu201097_CR47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.trim.2005.03.009","volume":"14","author":"IB Resnick","year":"2005","unstructured":"Resnick IB, Shapira MY, Slavin S . Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases. Transpl Immunol 2005; 14: 207\u2013219.","journal-title":"Transpl Immunol"},{"issue":"Suppl 2","key":"BFleu201097_CR48","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1038\/bmt.2008.48","volume":"41","author":"I Yaniv","year":"2008","unstructured":"Yaniv I, Stein J . Reduced-intensity conditioning in children: a reappraisal in 2008. Bone Marrow Transplant 2008; 41 (Suppl 2): S18\u2013S22.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu201097_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jaut.2009.09.002","volume":"33","author":"I Yaniv","year":"2009","unstructured":"Yaniv I, Ash S, Farkas DL, Askenasy N, Stein J . Consideration of strategies for hematopoietic cell transplantation. J Autoimmun 2009; 33: 255\u2013259.","journal-title":"J Autoimmun"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201097","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T09:21:39Z","timestamp":1648718499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,20]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["BFleu201097"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.97","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,20]]},"assertion":[{"value":"17 October 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}